Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

JPMorgan Chase & Co (NY: JPM )

240.85 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Jan 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 673
Open 240.85
Bid (Size) 241.00 (1)
Ask (Size) 241.78 (1)
Prev. Close 240.85
Today's Range 240.85 - 240.85
52wk Range 164.30 - 254.31
Shares Outstanding 3,082,400,000
Dividend Yield 2.08%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
JPMorganChase Survey: Businesses Ring in the New Year with Renewed Optimism
From JPMorgan Chase & Co.
Via Business Wire
Why Teradyne (TER) Stock Is Up Today
Shares of semiconductor testing company Teradyne (NASDAQ:TER) jumped 7.2% in the afternoon session after Northland analysts upgraded the stock's rating from Market Perform (Hold) to Outperform (Buy)... 
Via StockStory

Performance

YTD
+0.35%
+0.35%
1 Month
-1.21%
-1.21%
3 Month
+14.18%
+14.18%
6 Month
+17.39%
+17.39%
1 Year
+40.01%
+40.01%

More News

Read More
Optimum-MSGN Standoff Could Pressure MSG Networks' Finances: Analyst
Via Benzinga
Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
Via Benzinga
Market Whales and Their Recent Bets on JPM Options
Via Benzinga
Acquisition of Kadima Neuropsychiatry Institute for CNS & Psychedelic Research Planned; New Drug Application for Suicidal Depression Treatment: $NRXP
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Spotlight on JPMorgan Chase: Analyzing the Surge in Options Activity
Via Benzinga
JPMorgan Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Via Benzinga
Alphabet Drives Into 2025: Google's AI, Waymo Lead The Charge
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
GeoVax to Review 2024 Progress at Biotech Showcase During J.P. Morgan Healthcare Week 2025
Via NewMediaWire
GeoVax to Review 2024 Progress at Biotech Showcase During J.P. Morgan Healthcare Week 2025
Via TheNewswire.com
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Engage Investors and Partners at Key January Conferences
Via Investor Brand Network
New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects 13+ Million Americans Each Year: NRx Pharma: Stock Symbol:NRXP
Via PRLog
Exposures Product Safety
Here's How Trump Could Wipe Out 40% of Tesla's Profits After Taking Office, According To JPMorgan Analyst
Via Benzinga
Topics Government
Exposures Political
3 ETFs I'm Buying in January 2025
Via The Motley Fool
Topics ETFs
A Mass Exodus Of Big Banks From The Net-Zero Bank Climate Alliance
Via Talk Markets
Q4 Earnings Season Looms: A Preview
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
3 Top Value Stocks to Buy in January
Via The Motley Fool
Ranked: The World’s Top Companies By Revenue In 2024
Via Talk Markets
The question on everyone's mind: Will JPMORGAN CHASE & CO breakout?
Via Chartmill
Under the Radar: New Year, New Financial Frontiers -Beyond the Big Banks
Via Benzinga
3 Stocks Helping to Bring AI to Healthcare
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better
Via MarketBeat
Topics Economy Energy
Exposures Economy Fossil Fuels Interest Rates
Dow Jones 2024 Scoreboard: Top 5 Winners, Losers — And How Amazon, Nvidia Could Reshape 2025
Via Benzinga
Topics Stocks
Exposures US Equities
S&P 500 Earnings Set to Shine: January's Critical Market Test
Via MarketBeat
Topics Economy Stocks
Exposures Economy Interest Rates US Equities
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.